David Hanley
Vermögen: 114 720 $ am 31.05.2026
Vermögen: 114 720 $ am 31.05.2026
David C.
Hanley is Chief Technical Operations Officer at Nuvation Bio, Inc. since 2021.
Formerly, Senior Director-Global Pharmaceutical Development at The Medicines Co. from 2011 to 2014, VP-Pharmaceutical Sciences & Technical Operations at Radius Health, Inc. from 2014 to 2018, and Senior VP & Head-Global Pharmaceutical Development at BioXcel Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Utah and an undergraduate degree from Virginia Commonwealth University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.02.2026 | 24.000 ( 0,01 % ) | 114 720 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVATION BIO INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2021 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01.08.2018 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01.08.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Commonwealth University
Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Nuvation Bio, Inc.
Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen